COB Steven Burrill resigns. Replaced by Herbert Conrad.
On January 18, 2011, G. Steven Burrill notified the board of directors (the "Board") of Pharmasset, Inc. (the "Company") of his resignation as Chairman of the Board, Chairman of the Audit Committee of the Board and as a member of the Compensation Committee of the Board. At a meeting held after its receipt of notice of Mr. Burrill's resignation, the Board appointed Herbert J. Conrad to succeed Mr. Burrill as Chairman of the Board and as a member of the Audit Committee and Robert F. Williamson III to succeed Mr. Burrill as Chairman of the Audit Committee. Mr. Burrill's position on the Compensation Committee will not be filled, which leaves the Compensation Committee with three remaining members (Robert F. Williamson III (Chair), Elliot F. Hahn and Michael K. Inouye). The Board has determined that Mr. Williamson qualifies as an "audit committee financial expert" under the rules and regulations of the Securities and Exchange Commission and possesses financial sophistication in accordance with the requirements of The NASDAQ Stock Market, LLC.
